| Notice of Special Interest (NOSI): Improving Outcomes in Cancer Treatment-Related Cardiotoxicity |
NOT-CA-22-001 |
|
|
11/06/2024 |
|
| HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices |
RFA-NS-23-003 (RM1 Clinical Trial Optional) |
RM1 |
Clinical Trial Optional |
06/10/2025 |
|
| Health Care Models for Persons with Multiple Chronic Conditions from Populations that Experience Health Disparities: Advancing Health Care towards Health Equity |
PAR-22-092 (R01 - Clinical Trials Optional) |
R01 |
|
09/08/2024 |
Ellen Richmond, M.S., G.N.P.-B.C. |
| HEAL Initiative Notice of Special Interest (NOSI): Development and Validation of Pain-Related Models and Endpoints to Facilitate Non-Addictive Analgesic Discovery |
NOT-NS-22-095 |
|
|
06/25/2025 |
Rachel Altshuler, Ph.D. |
| HEAL Initiative: Development and Validation of Non-Rodent Mammalian Models of Pain |
RFA-NS-22-070 (R01 Clinical Trial Not Allowed) |
R01 |
Clinical Trial Not Allowed |
03/07/2024 |
|
| Patient-Clinician Relationship: Improving Health Outcomes in Populations that Experience Health Care Disparities |
PAR-22-064 (R01 Clinical Trial Optional) |
R01 |
Clinical Trial Optional |
01/08/2025 |
|
| Notice of Special Interest to Encourage Eligible NIH HEAL Initiative Awardees to Apply for PA-20-222: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) |
NOT-NS-20-107 |
|
Clinical Trial Not Allowed |
05/16/2024 |
|
| Notice of Special Interest (NOSI): HEAL Initiative: Clinical Translation of Diagnostic and Therapeutic Devices via Blueprint MedTech |
NOT-NS-23-002 |
|
|
06/21/2024 |
|
| NCI Clinical and Translational Exploratory/Developmental Studies |
PAR-22-216 (R21 Clinical Trial Optional) |
R21 |
Clinical Trial Optional |
07/02/2025 |
Marjorie Perloff, M.D. |
| HEAL Initiative: Team Research for Initial Translational Efforts in Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] |
RFA-NS-22-052 (U19 Clinical Trial Not Allowed) |
U19 |
Clinical Trial Not Allowed |
10/11/2023 |
Rachel Altshuler, Ph.D. |